News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
simplywall.st Earnings
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Investors with an interest in Medical - Products stocks have likely encountered both Perrigo (PRGO) and Neogen (NEOG). But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look. Everyone has their own methods …
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. Looking at the …
Sharemaestro market context Price below Trend Line 52 weeks -56.4% · Next-week setup negative 20.1%This article provides current stock news for Perrigo Company PLC (PRGO), including its latest market performance with a 2.31% gain and a market cap of $1.78 billion. The page details an overview of the company's financial information, stock score, and analyst ratings. It indicates …
Perrigo (PRGO) reported Q2 2026 results, exceeding earnings expectations despite a decline in sales due to soft consumer self-care categories and retailer inventory reductions. The company maintained its full-year outlook, anticipating improved category trends and market-share gains in the second half. Management emphasized continued …
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Perrigo stock has fallen sharply over the past few years, yet the current valuation checks suggest the market may now be pricing it …
Sharemaestro market context Price below Trend Line 52 weeks -56.4% · Next-week setup negative 20.1%This article provides an analyst report from Morningstar on Perrigo Company plc (PRGO), a consumer healthcare product manufacturer. The report highlights the company's recent infant formula recovery, which was met with excitement despite ongoing uncertainties. Perrigo specializes in private-label consumer health goods sold through …
Perrigo Company Plc recently exceeded its earnings expectations. This article will discuss what analysts anticipate for the company's future performance following this positive earnings report.
Perrigo Company plc (NYSE:PRGO) shareholders saw a 27% increase in their stake following better-than-expected quarterly profits, despite revenues meeting analyst forecasts. While analysts reconfirmed revenue estimates for 2026, they significantly increased per-share loss predictions, though the consensus price target remained unchanged at US$16.50. The …
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Why Perrigo Stock Is Back in Focus After Q2 Earnings Perrigo (PRGO) is drawing fresh attention after second quarter 2026 adjusted earnings per share came in ahead …
Sharemaestro market context Price below Trend Line 52 weeks -56.4% · Next-week setup negative 20.1%Quantinno Capital Management LP reduced its stake in Perrigo Company plc by 25.4%, selling 168,471 shares and retaining 493,866 shares valued at approximately $5.3 million. Despite a decline in sales, Perrigo's latest quarterly earnings beat expectations, and the company reaffirmed its fiscal 2026 EPS …
Perrigo Company plc reported Q2 2026 adjusted earnings of $0.50 per share, significantly exceeding analysts' $0.35 forecast by 42.9%. Despite this strong earnings beat, the company's revenue declined by 3.2% year-over-year to $1.02 billion, with organic net sales falling by 1.3%. Management provided a …
Perrigo (PRGO) reported strong second-quarter 2026 results, with All In adjusted earnings per share of 50 cents significantly beating the Zacks Consensus Estimate of 31 cents. Despite a decline in All In net sales to $1.02 billion, this still marginally surpassed the $1 billion …
This article first appeared on GuruFocus. Core Net Sales: Declined 3.1% year-over-year; core organic net sales declined 3.5%. All-in Net Sales: Declined 3.2% year-over-year. Infant Formula Net Sales: Grew 23% year-over-year, driven by timing of contract sales and growth in store brand formula. Core …
Perrigo Company Plc (PRGO) announced its second-quarter adjusted EPS of $0.50 per share, significantly exceeding the FactSet estimate of $0.34 per share. This financial beat indicates a stronger performance than anticipated by analysts for the quarter.
Perrigo Company plc (NYSE:PRGO) released its Q2 2026 earnings call presentation on August 5, 2026. The company reported an EPS of $0.50, beating estimates by $0.15, and revenue of $1.02 billion, exceeding expectations by $12.65 million despite a 3.17% year-over-year decrease. This presentation provides …
This page provides live quotes and charts for Perrigo Company plc (PRGO) stock on the NYSE. It shows the current stock price of $13.12, a gain of $2.34 (21.69%), but notes that prices are delayed. The article also includes sections for analyst ratings, though …
Sharemaestro market context Price below Trend Line 52 weeks -56.4% · Next-week setup negative 20.1%Perrigo Company plc announced Q2 2026 financial results, exceeding Wall Street expectations for earnings per share despite a decline in sales. The company reported adjusted EPS of $0.50, significantly above the $0.35 forecast, on revenue of $1.02 billion. Perrigo projects full-year 2026 adjusted earnings …
Perrigo (PRGO) reported Q2 2026 revenue of $1.02 billion, a 3.2% decrease year-over-year, and an EPS of $0.50, down from $0.57 in the prior year. Despite the revenue decrease, the company surpassed Zacks Consensus Estimates for both revenue and EPS. Key metric performance, including …
Sharemaestro market context Price below Trend Line 52 weeks -56.4% · Next-week setup negative 20.1%(RTTNews) - Perrigo Co. plc (PRGO), a provider of Consumer Self-Care Products, on Wednesday reported profit despite a decline in sales in the second quarter compared with loss in the previous year. For the second quarter, net income came in at $74.5 million compared …
Sharemaestro market context Price below Trend Line 52 weeks -56.4% · Next-week setup negative 20.1%Perrigo (PRGO) came out with quarterly earnings of $0.5 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.57 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings …
Sharemaestro market context Price below Trend Line 52 weeks -56.4% · Next-week setup negative 20.1%Execution of Three-S plan driving continued improvement in underlying business fundamentals, including market share growth in U.S. store-brand OTC and key European brands Streamlined portfolio through completion of Dermacosmetics divestiture and continuing strategic reviews of Infant Formula and Oral Care businesses Reaffirmed full-year 2026 …
Perrigo Company Plc (PRGO) presents a potential investment opportunity with an analyst-projected upside of 54.49%, despite recent declines from its 52-week high and current financial challenges. The company, a healthcare sector stalwart known for OTC health and wellness products, trades near its 52-week low. …
Perrigo Co. PLC (PRGO) saw its stock rise by 5.64% to $10.68 on Monday, outperforming the broader market, which also experienced a strong trading session. This increase broke a two-day losing streak for the company's shares. The S&P 500 Index and Dow Jones Industrial …
Dimensional Fund Advisors LP significantly reduced its stake in Perrigo Company plc by 11.3% in the first quarter, selling 838,228 shares, but still holds 6.57 million shares valued at approximately $70.5 million. Perrigo's recent quarterly earnings beat estimates with $0.43 EPS but revenue declined …
Search by ticker symbol or company name and select a result to open its chart.